Elecsys^® BRAHMS Procalcitonin (PCT)

Sepsis is life threatening organ dysfunction caused by a dysregulated host response to infection.^5,6,7 Sepsis and septic shock are major healthcare problems, with more than 1 in 1000 people in developed countries suffering from sepsis each year.⁸ Early identification and appropriate management in the initial hours after sepsis develops improves outcomes.⁹

Elecsys^® BRAHMS PCT helps sepsis patient management by providing valuable data about the source of a suspected infection, disease severity & progression, and response to treatment.

PCT levels increase as sepsis progresses and severity increases, allowing the differentiation of patients with SIRS, sepsis, severe sepsis or septic shock. PCT is a biomarker with high specificity for an inflammatory response to a bacterial infection. PCT concentrations in the blood can aid clinicians in the detection of clinically relevant bacterial infections. PCT is considered a prognostic marker to support outcome prediction in sepsis patients. PCT can be used for decision of antibiotic treatment necessity and to monitor treatment success in LRTI.^{1, 2, 3, 4}

Elecsys^® BRAHMS PCT helps personalise your sepsis patient management by providing reliable real-time clinical decision support data about the source of a suspected infection, disease severity & progression, and response to treatment.

PCT levels increase as sepsis progresses and severity increases, allowing the differentiation of patients with SIRS, sepsis, severe sepsis or septic shock. PCT is a biomarker with high specificity for an inflammatory response to a bacterial infection. PCT concentrations in the blood can aid clinicians in the detection of clinically relevant bacterial infections. PCT is considered a prognostic marker to support outcome prediction in sepsis patients. PCT can be used for decision of antibiotic treatment necessity and to monitor treatment success in LRTI.^{1, 2, 3, 4}

Sepsis is life threatening organ dysfunction caused by a dysregulated host response to infection.^5,6,7 Sepsis and septic shock are major healthcare problems, with more than 1 in 1000 people in developed countries suffering from sepsis each year.⁸ Early identification and appropriate management in the initial hours after sepsis develops improves outcomes.⁹

• Aids in the early detection of clinically relevant bacterial infections
• Guide for the decision of antibiotic treatment necessity and to monitor treatment success in LRTI
• Specific for bacterial infections, not viral or fungal¹⁰

• Correlates with sepsis severity categories ¹¹ and SOFA score categories ¹²
  

Elecsys BRAHMS PCT helps to improve your sepsis patient management by providing reliable realtime clinical decision support data about a suspected infection, disease severity, and response to treatment.

• Low sample volume
• Broad measuring range
• Short total assay time
• Excellent inter- and intra-assay CV (coefficient of variation)
• Available on all cobas e analyzers